American Society of Hematology

ASH Pocket Guides Conflicts of Interest

Management of Anticoagulation Therapy

Daniel M. Witt, PharmD, University of Utah
Nathan P. Clark, PharmD, Kaiser Permanente Colorado
Jane Skov, PhD, MSc, University of Southern Denmark
Mark Crowther, MD, MSc, McMaster University

Drs. Clark, Skov, and Crowther declare no competing financial interests. Dr. Witt has received funding from Roche Diagnostics.

back to top

Venous Thromboembolism (VTE) in the Context of Pregnancy

Shannon M. Bates, MDCM, MSc, McMaster University
Anita Rajasekhar, MD, MS, University of Florida
Claire McLintock, MD, National Women’s Health, Auckland City Hospital

Conflict of interest information pending.

back to top

Diagnosis and Management of Heparin-Induced Thrombocytopenia (HIT)

Allyson M. Pishko, MD, University of Pennsylvania
Lori-Ann Linkins, MD, MSc, McMaster University
Theodore E. Warkentin, MD, McMaster University
Adam Cuker, MD, MS, University of Pennsylvania

Drs. Pishko, Linkin, Warkentin, and Cuker declare no competing financial interests.

back to top

Management of Immune Thrombocytopenia (ITP)

Cindy Neunert, MD, Columbia University Medical Center
Sara K. Vesely, PhD, University of Oklahoma Health Sciences Center
Siraj Mithoowani, MD, McMaster University
Taylor Kim, MD, Baylor College of Medicine

Conflict of interest information pending.

back to top

Cardiopulmonary and Kidney Disease in Sickle Cell Disease: Screening and Management

Robert I. Liem, MD, Ann & Robert H. Lurie Children’s Hospital of Chicago
Sophie Lanzkron, MD, Johns Hopkins School of Medicine
Madeleine Verhovsek, MD, FRCPC, McMaster University
Ifeyinwa (Ify) Osunkwo, MD, MPH, The Levine Cancer Institute – Atrium Health

Conflict of interest information pending.

back to top

2013 Clinical Practice Guide on Thrombocytopenia in Pregnancy

Anita Rajasekhar, MD, MS
Terry Gernsheimer, MD
Roberto Stasi, MD, PhD
Andra H. James, MD, MPH

No declared conflicts of interest.

back to top

Management of Acute Complications of Sickle Cell Disease

Timothy McCavit, MD, MSCS, University of Texas Southwestern Medical Center
Payal Desai, MD, The Ohio State University, the James Cancer Center

Dr. Desai is a consultant for Pfizer. Dr. McCavit is a consultant for Pfizer and was previously a consultant for GlycoMimetics.

back to top

Health Maintenance and Management of Chronic Complications of Sickle Cell Disease

Suzie A. Noronha, MD, University of Rochester Medical Center
Sophie Lanzkron, MD, Johns Hopkins University School of Medicine

Dr. Lanzkron receives research funding from Selexys Pharmaceuticals and from NKT Therapeutics. Dr. Noronha receives research funding from Mast Therapeutics.

back to top

Hydroxyurea and Transfusion Therapy for the Treatment of Sickle Cell Disease

Susan E. Creary, MD, MSc, The Ohio State University School of Medicine
John J. Strouse, MD, PhD, Johns Hopkins University School of Medicine

Dr. Creary declares no competing financial interests. Dr. Strouse is co-investigator on an NHLBI grant, 1R34HL108756-01, to study hydroxyurea for the primary prevention of central nervous system disease in young children with sickle cell anemia.

back to top

Initial Diagnostic Workup of Acute Leukemia

Melissa H. Cessna, MD, Intermountain Healthcare and Utah Pathology Services, Inc.
Sa A. Wang, MD, The University of Texas MD Anderson Cancer Center

Drs. Cessna and Wang declare no competing financial interests.

back to top

Monoclonal Gammopathy of Undetermined Significance (MGUS): Diagnosis, Predictors of Progression, and Monitoring

Brea C. Lipe, MD University of Rochester Medical Center
Robert A. Kyle, MD Mayo Clinic, Rochester, MN

Drs. Lipe and Kyle declare no competing financial interests.

back to top

Red Blood Cell Transfusion

Robert Weinstein, MD, University of Massachusetts Medical School

Dr. Weinstein declares no competing financial interests.

back to top

2012 Clinical Practice Guideline on the Evaluation and Management of von Willebrand Disease (VWD)

No authors listed back to top

2011 Clinical Practice Guideline on the Evaluation and Management of Immune Thrombocytopenia (ITP) -DISCONTINUED

No authors listedback to top

Clinical Practice Guide on Antithrombotic Drug Dosing and Management of Antithrombotic Drug-Associated Bleeding Complications in Adults- DISCONTINUED

Mary Cushman, University of Vermont
Wendy Lim, McMaster University
Neil A. Zakai, University of Vermont back to top